Pharmaceutical partnerships have received unprecedented press in the last year, and with good reason– there are many social and economic benefits to engaging with distributors and other types of partners. Delegating pharmaceutical, and therefore pharmacovigilance, activities introduces operational and regulatory complexity. Until now, the management and oversight of governing contracts like PV Agreements has largely been a manual, cumbersome process. 

Leading organizations have found a better way. In the on-demand webinar, join Michelle Peralta and Katherine Long from the Orbit team as they discuss practical strategies and solutions to meet the regulatory burden around PV partnerships.